| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0004 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |